Posts

Showing posts with the label molecular diagnostics

Global Cancer Biomarkers Market to US$58 Billion by 2032 Driven by Precision Oncology and Liquid Biopsy Advancements

Image
Industry Experts, Inc. has released its latest market research report, " Global Cancer Biomarkers Market - Types, Applications and Technologies ," estimating that the global cancer biomarkers market will expand from US$27.6 billion in 2025 to US$58 billion by 2032, registering a strong CAGR of 11.2% during 2025-2032. Growth is being driven by the rising global cancer burden, increasing emphasis on early and accurate diagnosis, and rapid adoption of biomarker-guided precision oncology. Cancer biomarkers are measurable biological indicators that support cancer detection, prognosis, treatment selection, and therapy monitoring across a wide range of malignancies. Increasing reliance on molecular profiling to guide targeted therapies, combined with growing adoption of liquid biopsy techniques based on circulating tumor DNA (ctDNA), circulating tumor cells (CTCs), and exosomes, has significantly expanded the clinical role of biomarkers. Advances in next-generation seque...

Global Autoimmune Disease Diagnostics Market to Surpass US$10 Billion by 2032 Rising Driven by Disease Burden and Personalized Testing

Image
Industry Experts, Inc. has introduced its latest market research report, " Autoimmune Disease Diagnostics - A Global Market Overview ," estimating that worldwide revenues will rise from US$6.2 billion in 2025 to US$10.2 billion by 2032 , growing at a CAGR of 7.5% during 2025 to 2032. Market expansion is driven by the rising global prevalence of more than 100 autoimmune disorders, including rheumatoid arthritis, lupus, multiple sclerosis, and type 1 diabetes, coupled with heightened awareness, early testing initiatives, and technological advancements in immunoassays, biomarkers, and molecular diagnostics. Advances in genomics, proteomics, bioinformatics, and AI-driven automation are significantly improving sensitivity, specificity, and turnaround time across diagnostic platforms. Growing adoption of multiplex and next-generation sequencing assays, together with machine-learning–based interpretation tools, is enabling precision diagnostics and personalized m...

Global Cancer Diagnostics Market to Reach US$153 Billion by 2032, Driven by Precision Medicine, Early Detection, and AI-Enabled Imaging

Image
Industry Experts, Inc. has published the new market research report " Global Cancer Diagnostics Market - Technologies, Applications and End-Use Facilities ." The study estimates the worldwide cancer diagnostics market at US$95.3 billion in 2025, projected to expand to US$153 billion by 2032, growing at a CAGR of 7% during 2025–2032. Growth is underpinned by rising global cancer incidence, government screening initiatives, increasing adoption of precision medicine, and technological advancements such as liquid biopsy, next-generation sequencing, and AI-powered imaging platforms that enhance diagnostic accuracy and efficiency. The report highlights North America as the largest regional market, commanding 39.8% share in 2025, supported by robust healthcare infrastructure, advanced R&D ecosystems, favourable reimbursement policies, and strong adoption of innovative diagnostic modalities. The U.S. dominates within the region due to high screening rates and estab...

Global Market for Molecular Diagnostics is Projected to Touch $32 billion by 2030 Driven by Demand for Early Detection of Disease and Need for Personalized Treatment

Image
A new report from Industry Experts, Inc. on " Molecular Diagnostics Market " is introduced. According the report, the market is poised for a robust expansion over the 2024-2030 forecast period, with a projected CAGR of 10% in value. The market is expected to reach about US$32 billion by 2030, up from an estimated US$18 billion in 2024. The molecular diagnostics market is growing rapidly, driven by a growing need for faster and more accurate disease detection. With the increasing number of infectious diseases like HIV, tuberculosis, and respiratory infections, healthcare providers rely on molecular tests to quickly identify pathogens and guide treatment. Cancer diagnostics is another major driver, as these tests help detect genetic mutations like BRCA1/2, EGFR, and KRAS, allowing doctors to create personalized treatment plans. Progress in PCR, Next-Generation Sequencing (NGS), and DNA Microarrays made testing more accurate, inexpensive, and widely available. Gove...

COVID-19 Outbreak Drives Infectious Diseases to Witness Highest Growth and Helps Global Molecular Diagnostics Market to Touch $25 Billion by 2026 - Market Report (2019-2026) by Industry Experts, Inc.

Image
Industry Experts, Inc. published an updated 2020 version of their market research report " Global Molecular Diagnostics Market – Technologies, Products, Applications and End-Use Sectors " with the COVID-19 influence on the market. Analysts at Industry Experts reveal that the reagents & consumables market is largest amongst the molecular diagnostics product types in 2019 estimated at US$8.2 billion. Amid COVID-19 outbreak, the global market for Molecular Diagnostics has created mixed opportunities for manufacturers all over the world. While some of the application segments, such as infectious diseases, is projected to record the highest growth during the pandemic period of 2019-2022, but other applications such as oncology etc. are estimated to face a reduction in demand during the same period. Global Molecular Diagnostics market has generated a revenue of US$10.85 billion in 2019, and is estimated to be just over US$15 billion in 2020. During 2019 to 2022 period, ...

Growing Prevalence of Genetic Disorders and Growth Driven by Hospitals & Diagnostic Labs, Global Molecular Diagnostics Market is projected to Touch $20 Billion by 2024 - Market Report (2017-2024) by Industry Experts, Inc.

Image
Industry Experts, Inc. published the new market research report " Global Molecular Diagnostics Market – Technologies, Products, Applications and End-Use Sectors ". Analysts at Industry Experts reveal that the reagents & consumables market is largest amongst the molecular diagnostics product types in 2018 estimated at US$7.1 billion. Emergence of novel next generation sequencing technologies, extensive use of next generation sequencing technologies in clinical diagnostics, application of sequencing technologies in cancer to detect mutations are some of the factors fueling the growth of sequencing technologies usage in the molecular diagnostics field. Growing prevalence of genetic disorders, rising demand for personalized medicine etc., are some of the factors attributed to the fastest growth nature of molecular diagnostics applications in Genetic testing. The market for Molecular Diagnostics applications analyzed in this study includes Infectious Diseases, Oncology, ...